❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Tumor Biology ❭
Page visits: 29
Scroll to top

Home Institute for Cancer Research Dept. of Tumor Biology

  • Resources and expertise
  • Kjersti Flatmark's group
  • Eivind Hovig's group
  • Jørgen Wesche's group
  • G. Mælandsmo's group
  • Project groups Tumor Biology
  • Publications
  • Staff
  • Vacant positions
  • News

Recent publications

Krossa S, Andersen MK, Sandholm EM, Wess M, Kiviaho A, Sharma A, Hakkola S, Hao Y, Alshalalfa M, Davicioni E, Viset T, Størkersen Ø, Karnes RJ, Spratt DE, Giskeødegård GF, Nykter M, Rye MB, Urbanucci A, Tessem MB (2025)
Spatial multi-omics identifies aggressive prostate cancer signatures highlighting pro-inflammatory chemokine activity in the tumor microenvironment
Nat Commun, 16 (1), 10160
DOI 10.1038/s41467-025-65161-9, PubMed 41258098

Wang S, Santacana-Font G, Kedra D, Gilfillan S, Tena-Chaves D, Bergholtz H, Engebraaten O, Lingjaerde OC, Gutiérrez-Fernández J, Norum JH, Sørlie T, López-Aviles S, Hurtado A (2025)
The harmonized activities of HER2-HER3 heterodimer and deacetylated FOXA1 evade hormone response by regulating FOXA1 chromatin binding
Nucleic Acids Res, 53 (20)
DOI 10.1093/nar/gkaf1086, PubMed 41224124

Lamsal A, Andersen SB, Nonstad U, Kurganovs NJ, Skipworth RJ, Bjørkøy G, Pettersen K (2025)
Correction: A role of arginase-1-expressing myeloid cells in cachexia
Cancer Metab, 13 (1), 44
DOI 10.1186/s40170-025-00412-3, PubMed 41204350

More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)